Bohdan Andreiuk
Senior Scientist - New Modality Preformulation & Lipid Nano Particle Formulation AstraZeneca
Dr. Bohdan Andreiuk is a Senior Scientist in the Advanced Drug Delivery department at AstraZeneca, with over 10 years of experience in the design, synthesis, and characterization of nanoparticles across multiple modalities, including lipid, polymeric, and metallic systems. His work spans a broad range of applications such as gene and drug delivery and bioimaging. Currently, he focuses on the formulation development of mRNA‑LNPs and tLNPs for vaccines, gene therapies, and protein replacement therapies.
Seminars
Wednesday 3rd June 2026
Panel Discussion: Exploring the Future of Extrahepatic LNPs to Overcome Delivery Barriers, Expand Therapeutic Reach, & Unlock Novel Disease Treatments
2:40 pm
- What are the remaining barriers for achieving efficient, organ-specific delivery to difficult targets?
- Which design strategies and technologies are most promising for enabling precise extrahepatic targeting while minimizing liver accumulation?
- What unmet therapeutic needs could next-generation extrahepatic LNPs address to expand the RNA, gene editing, and cell therapy landscape?
